Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA3 | P07451 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA6 | P23280 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.34 |
| ▸ | INMT | O95050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
| ▸ | BRD2 | P25440 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9551031 | 1.00 | LMNA (0.34) | LMNAKMT2ACA12CA1CA2 | |
| SCHEMBL10443871 | 0.87 | LMNA (0.35) | LMNAKMT2ACA12CA1CA2 | |
| SCHEMBL8356553 | 0.87 | PTGER4 (0.34) | LMNAKMT2ACA12CA1CA2 | |
| SCHEMBL2789309 | 0.86 | KMT2A (0.33) | LMNAKMT2ACA12CA1CA2 | |
| SCHEMBL4785170 | 0.86 | KMT2A (0.33) | LMNAKMT2ACA12CA1CA2 | |
| SCHEMBL3799906 | 0.85 | KMT2A (0.31) | LMNAKMT2ACA12CA1CA2 | |
| SCHEMBL34237 | 0.85 | KMT2A (0.34) | LMNAKMT2ACA12CA1CA2 | |
| SCHEMBL5292575 | 0.85 | KMT2A (0.34) | LMNAKMT2ACA12CA1CA2 | |
| SCHEMBL11109025 | 0.84 | EP300 (0.40) | — | |
| SCHEMBL8356667 | 0.84 | EP300 (0.37) | INMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7008990-B2 | Use of polymeric reaction product | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-07 | — | — | US | disclosed |
| US-6815498-B2 | BLOCK POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-09 | — | — | US | disclosed |
| US-6710024-B2 | Washing active preparation | BASF AKTIENGESELLSCHAFT (DE) | 2004-03-23 | — | — | US | disclosed |
| US-20040034182-A1 | Method for the production of a polymerisation reaction product | BASF AKTIENGESELLSCHAFT (DE) | 2004-02-19 | — | — | US | disclosed |
| US-20040014872-A1 | Bonding agent composition containing solid matter, with radically polymerised block copolymers | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-22 | — | — | US | disclosed |
| US-20030170306-A1 | Use of polymeric reaction product | BASF AKTIENGESELLSCHAFT (DE) | 2003-09-11 | — | — | US | disclosed |
| US-20030109414-A1 | Washing active preparation | BASF AKTIENGESELLSCHAFT (DE) | 2003-06-12 | — | — | US | disclosed |
| US-20030018137-A1 | Method for producing a polymeric conversion product | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-23 | — | — | US | disclosed |
| US-6015910-A | SYSTEMIC INSECTICIDES WHICH ARE NONTOXIC TO MAMMALS AND AQUATIC ORGANISMS | RHONE-POULENC INC. (US) | 2000-01-18 | — | — | US | disclosed |
| US-5883112-A | INSECTICIDES | RHONE-POULENC INC. (US) | 1999-03-16 | — | — | US | disclosed |
| US-5814652-A | SYSTEMIC INSECTICIDES | RHONE-POULENC INC. (US) | 1998-09-29 | — | — | US | disclosed |
| WO-1997022593-A1 | NOVEL 5-AMINO-3-CYANO-4-ETHYLSULFINYL-1-PHENYL-PYRAZOLE COMPOUNDS AND THEIR USE AS PESTICIDES | RHONE-POULENC AGROCHIMIE (FR) | 1997-06-26 | — | — | WO | disclosed |
| US-5258227-A | Vinylpyrrolidone-acrylic acid copolymer | PPG INDUSTRIES, INC. (US) | 1993-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030170306-A1 | Use of polymeric reaction product | OXSR1, OGFR, CBR1 | LMNA 1810/4885KMT2A 2302/4885CA12 2464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.